Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Hyde Joseph R III
Relationship:   Director
City:   Memphis
State:   TN
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   4,411,298    

Indirect Shares

   2,672,247      
Direct Value   $235,016,621    

Indirect Value

   $6,500,627      
Total Shares   7,083,545      
Total Value   $241,517,248      


Fedex Corp $32,681,880 Oncternal Therapeutics Inc $1,441,444 Autozone Inc $200,893,297 Fedex Corp $32,681,880 Oncternal Therapeutics Inc $1,441,444 Autozone Inc $200,893,297
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Fedex Corp FDX Director 2009-04-29 132,000 2008-11-03 0    Premium*  
            Oncternal Therapeutics Inc ONCT Director, 10% Owner 2019-01-02 4,207,368 2019-01-02 2,670,247    Premium*  
            Autozone Inc AZO Director 2018-01-01 71,930 2018-01-01 2,000    Premium*  
* Premium Members only  

Records found :    178         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 6 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ONCT Oncternal Therapeutics In... Director   –       •       •   2010-05-10 4 B $3.32 $66,440 I/I 20,000 794,914 2.25 -
ONCT Oncternal Therapeutics In... Director   –       •       •   2010-05-11 4 B $3.59 $71,820 I/I 20,000 814,914 2.25 -
ONCT Oncternal Therapeutics In... Director   –       •       •   2010-05-12 4 B $3.70 $92,525 I/I 25,000 839,914 2.25 -
ONCT Oncternal Therapeutics In... Director   –       •       •   2010-05-17 4 B $3.74 $10,452 I/I 2,794 845,109 2.17 -
ONCT Oncternal Therapeutics In... Director   –       •       •   2010-05-27 4 B $2.04 $408,000 I/I 200,000 1,045,109 2.25 -
ONCT Oncternal Therapeutics In... Director   –       •       •   2010-05-28 4 B $2.01 $301,500 I/I 150,000 1,195,109 2.25 -
ONCT Oncternal Therapeutics In... Director   –       •       •   2010-06-01 4 B $2.07 $186,300 I/I 90,000 1,285,109 2.25 -
ONCT Oncternal Therapeutics In... Director   –       •       •   2010-06-02 4 B $2.16 $208,991 I/I 96,755 1,381,864 2.25 -
ONCT Oncternal Therapeutics In... Director   –       •       •   2010-06-03 4 B $2.41 $117,078 I/I 48,580 1,430,444 2.25 -
ONCT Oncternal Therapeutics In... Director   –       •       •   2010-06-04 4 B $2.69 $201,750 I/I 75,000 1,505,444 2.25 -
ONCT Oncternal Therapeutics In... Director   –       •       •   2010-06-07 4 B $2.60 $431,961 I/I 166,139 1,671,583 2.25 -
ONCT Oncternal Therapeutics In... Director   –       •       •   2010-06-08 4 B $2.60 $114,746 I/I 44,133 1,715,716 2.25 -
ONCT Oncternal Therapeutics In... Director   –       •       •   2010-07-01 4 A $3.05 $9,000 D/D 2,951 5,581,023 0 -
ONCT Oncternal Therapeutics In... Director   –       •       •   2010-10-01 4 A $3.44 $9,000 D/D 2,616 5,583,640 0 -
ONCT Oncternal Therapeutics In... Director   –       •       •   2010-11-01 4 B $2.80 $6,160,000 I/I 2,200,000 3,915,716 2.25 -
ONCT Oncternal Therapeutics In... Director   –       •       •   2010-11-01 4 B $2.80 $9,150,000 D/D 3,267,857 8,851,497 3.92 -
ONCT Oncternal Therapeutics In... Director   –       •       •   2011-01-01 4 A $2.65 $9,750 D/D 3,679 9,731,380 0 -
ONCT Oncternal Therapeutics In... Director   –       •       •   2011-04-01 4 A $2.57 $9,000 D/D 3,502 9,734,882 0 -
ONCT Oncternal Therapeutics In... Director   –       •       •   2011-06-28 4 B $4.75 $4,631,250 D/D 975,000 10,709,882 3.92 -
ONCT Oncternal Therapeutics In... Director   –       •       •   2011-07-01 4 A $4.79 $8,250 D/D 1,722 10,941,802 0 -
ONCT Oncternal Therapeutics In... Director   –       •       •   2011-10-01 4 A $3.35 $8,250 D/D 2,463 9,298,913 0 -
ONCT Oncternal Therapeutics In... Director   –       •       •   2012-07-01 4 A $3.52 $8,250 D/D 2,344 9,581,736 0 -
ONCT Oncternal Therapeutics In... Director   –       •       •   2012-10-01 4 A $4.58 $8,250 D/D 1,801 9,957,410 0 -
ONCT Oncternal Therapeutics In... Director   –       •       •   2013-01-01 4 A $4.20 $16,375 D/D 3,899 9,132,861 0 -
ONCT Oncternal Therapeutics In... Director   –       •       •   2013-04-01 4 A $4.04 $13,625 D/D 3,373 9,405,014 0 -
  178  Records found
  1   2   3   4   5   6  7   8      
  Page 6 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us